Solvay Shares Bounce Back 2% Against a Declining Market

UBS Adjusts Solvay's Price Target

Last Monday, Swiss bank UBS revised its price target for Solvay, lowering it from €28 to €27, while maintaining a neutral recommendation on the stock. This new target still represents a potential revaluation of approximately 2.7% compared to the current price of €26.28. This downward revision comes in a context of unfavorable annual performance for the Belgian chemical company, whose stock has lost nearly a quarter of its value over twelve months. The next quarterly results, expected on May 7, will be a crucial event, followed by the general meeting scheduled for May 12.

Solvay's Stock Performance Remains Under Key Moving Averages

Despite today's rise, Solvay's stock price remains below its main moving averages: the 50-day moving average is at €26.70 and the 200-day moving average at €27.66, two levels the stock has not consistently surpassed in recent weeks. Trading below these benchmarks indicates a still fragile underlying trend. The RSI, an indicator measuring the ratio of recent upward and downward movements, stands at 37, close to the oversold zone typically set at 30. This positioning signals an excess of selling pressure in recent sessions, which can sometimes precede a technical correction. The major support identified is at €24.80, a threshold that has contained recent declines. Over the week, the variation remains almost unchanged at -0.15%, illustrating a consolidation phase after several weeks of decline.